Adrafinil

Research chemical

A prodrug to modafinil, this compound is often used to increase wakefulness and alertness. Due to hepatic metabolism it has a slower onset than modafinil and may cause liver damage in excess. Some users have reported acne as an adverse effect. Unregulated in the US.

Extended library — TripSit data only (PolyForm Noncommercial 1.0.0).

Before you dose

⚠This substance's dose is not reliably weight-scaled - the ranges shown are population figures. Sensitivity varies far more between people than body mass explains.

Dose

Published population range

Threshold100 mg

Light150–250 mg

Common250–400 mg

Heavy / risk zone≥ 600 mg

No weight-based model. Unknown potency — start far below any published figure.

Check an amount you already have

Expected effects

Stimulation
Dehydration
Headaches
Photophobia
Appetite suppression
Increased heart rate
Dizziness
Nausea
Body odor alteration
Wakefulness

Harm reduction

This entry comes from the extended library: it is a less-studied substance with fewer independent sources.
Unknown potency is the main risk with novel substances — start with a fraction of any published figure and never re-dose before the full onset has passed.
Test with reagents and, where possible, a lab service. Fentanyl and nitazene contamination is not detectable by eye or by reagent alone.
Avoid using alone, and do not combine with other drugs while you are learning how a new substance affects you.

Sources

• TripSit wiki (PolyForm Noncommercial)
https://wiki.tripsit.me

Dosina is educational harm-reduction information, not medical advice. Doses are population ranges from published sources and cannot account for your tolerance, health conditions or what is actually in your substance. Possession and use may be illegal where you live.